Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 1997

View Archived Issues

Gruenenthal prepares analgesics

Analgesic/antiinflammatory agent from Merck KGaA

Dual-action compounds for BPH described by Zeria

Antifungal agent revealed by Bayer

ADIR prepares antiangiogenic agents

German researchers focus on Na+/H+-exchange inhibitors

Antitumor agents from Taiho

Novel omega-conotoxin peptides described

Dual leukotriene/thromboxane antagonists described by Hokuriku

Natural 5alpha-reductase inhibitors discovered at Taisho

Meiji Milk discloses new gold complex

Patent coverage granted for LXR antidiarrheal agent

Novavax retains investment bank for licensing

Medis El teams with Ramot to develop breast cancer vaccines

Catalytica to acquire Glaxo Wellcome pharmaceutical facility

TCPI and Taiho agreement for diagnostic test

Vyrex gene discovery platform receives patent coverage

Rotavirus diagnostic approved in Germany

Milestone achieved in Microcide/Pfizer collaboration

Pall establishes European manufacturing site

Grant helps fund research into camptothecin analogues

Structure of protease involved in osteoporosis solved

Introgen receives milestone payment for gene therapy progress

Launch date for Aricept revealed

Genentech funds basic research related to human birth defects

BioSpecifics Technologies is issued 9th U.S. patent for use of collagenase enzyme

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...